510(k) Report

510(k) · Cleared

Cleared

Neuro-Patch

K960470510(k) TraditionalCleared May 10, 199699-day reviewClass II21 CFR 882.5910

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aesculap, Inc. · GXQ Dura Substitute

Cleared on May 10, 1996 after a 99-day review. The FDA summary names its predicate without a number. 15 later devices descend from it.

Decided
May 10, 1996
Review
99 days
Class
Class II
Product code
GXQ
Recalls
None
Predicates
0

15 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2000: 1 descendant cleared2016: 3 descendants cleared2004: 2 descendants cleared2003: 1 descendant cleared2013: 1 descendant cleared2015: 1 descendant cleared2017: 1 descendant cleared2023: 2 descendants cleared2026: 2 descendants cleared2020: 1 descendant cleared1995200020052010201520202025
  1. This deviceK960470 Neuro-PatchAesculap, Inc. · 1996
  2. Descendant · cites it directly · 14 of its ownK991413 Codman Ethisorb Dura PatchJohnson & Johnson Professionals, Inc. · 2000
  3. Descendant · 2 generations on · 7 of its ownK153613 Cerafix Dura SubstituteAcera Surgical, Inc. · 2016
  4. Descendant · 3 generations on · 6 of its ownK161278 Cerafix Dura SubstituteAcera Surgical, Inc. · 2016
  5. Descendant · 4 generations on · 4 of its ownK170300 Restrata Wound MatrixAcera Surgical, Inc. · 2017 · Recalled
  6. Descendant · 2 generations on · 2 of its ownK033395 Codman Dural Graft Implant, Models 80-1471, 80-1472, 80-1473…Codman & Shurtleff, Inc. · 2004

Showing 5 of 15 descendants. See all descendants

Descendants cleared per year

2000: 12003: 12004: 22013: 12015: 12016: 32017: 12020: 12023: 22026: 2
2000high 3 (2016) · low 0 (2001)2026

Most influential descendants

Showing 5 of 15 · See all
  • K991413Codman Ethisorb Dura PatchJohnson & Johnson Professionals, Inc. · 2000 · cites it directly14descendants
  • K153613Cerafix Dura SubstituteAcera Surgical, Inc. · 2016 · 2 generations on7descendants
  • K161278Cerafix Dura SubstituteAcera Surgical, Inc. · 2016 · 3 generations on6descendants
  • K170300Restrata Wound MatrixAcera Surgical, Inc. · 2017 · 4 generations on4descendants
  • K033395Codman Dural Graft Implant, Models 80-1471, 80-1472, 80-1473, 80-1474, 80-1475, 80-1476…Codman & Shurtleff, Inc. · 2004 · 2 generations on2descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K960470Neuro-PatchAesculap, Inc.1996—
+1K991413Codman Ethisorb Dura PatchJohnson & Johnson Professionals, Inc.2000—
+2K153613Cerafix Dura SubstituteAcera Surgical, Inc.2016—
+3K161278Cerafix Dura SubstituteAcera Surgical, Inc.2016—
+4K170300Restrata Wound MatrixAcera Surgical, Inc.20171
+2K033395Codman Dural Graft Implant, Models 80-1471, 80-1472, 80-1473, 80-1474…Codman & Shurtleff, Inc.2004—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200010
200310
200420
201310
201510
201630
201710
202010
202320
202620
FIG. 1 — Lineage of K960470, 1996–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GXQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GXQ device

  1. #1 K251191 Collagen Dura Regeneration Membrane - Repairscore 12.2 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Dura Film
Named without a submission number
—
*—Preclude Dura Substitute
Named without a submission number
—
*—Tutoplast® Dura substitute
Named without a submission number
—
*—Dura-Guard™ Dural Repair Patch
Named without a submission number
—

What descends from it? (15)

See all 15

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K991413Codman Ethisorb Dura PatchJohnson & Johnson Professionals, Inc.200014

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K991413 (Johnson & Johnson Professionals, Inc., 2000) has gone furthest, with 14 descendants of its own.

How does its category compare?

All GXQ devices

GXQ Dura Substitute: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GXQ

2in 2025

2007: 22010: 12012: 22013: 32014: 12015: 32016: 32017: 22019: 12022: 12023: 12025: 2
2007high 3 (2013) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GXQ

94in 2016

2013: 181 days median2015: 214 days median2016: 94 days median
2007high 214 (2015) · low 94 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GXQ

2in 2024

2010: 62013: 12021: 22024: 2
2007high 6 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GXQ

61in 2025

2007: 552008: 432009: 462010: 362011: 312012: 382013: 722014: 182015: 622016: 582017: 572018: 942019: 632020: 1142021: 762022: 592023: 1092024: 552025: 61
2007high 114 (2020) · low 18 (2014)2025

MAUDE reports naming product code GXQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—055
20080—043
20090—046
20101—636
20110—031
20122—038
20133181172
20141—018
20153214062
2016394058
20172—057
20180—094
20191—063
20200—0114
20210—276
20221—059
20231—0109
20240—255
20252—061
20260—0—

What is it indicated for?

Neuro-Patch (like its predicate devices) is indicated as a dura mater substitute in neurological procedures for soft tissue reconstruction of damaged, impaired, or missing tissue.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K960470: Neuro-Patch.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K960470

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026